PMID- 31258312
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20201001
IS  - 1052-1372 (Print)
IS  - 1052-1372 (Linking)
VI  - 44
IP  - 7
DP  - 2019 Jul
TI  - Alpha-1 Antitrypsin Replacement in Patients With COPD.
PG  - 412-415
AB  - Chronic obstructive pulmonary disease can be attributed to genetic conditions and 
      predispositions, among other factors. Alpha-1 antitrypsin deficiency (AATD) is a 
      significant risk factor for COPD development and progression, and aggressive 
      screening for all patients with COPD or adult-onset asthma is encouraged.
FAU - Wells, Adam D
AU  - Wells AD
FAU - Woods, Anna
AU  - Woods A
FAU - Hilleman, Daniel E
AU  - Hilleman DE
FAU - Malesker, Mark A
AU  - Malesker MA
LA  - eng
PT  - Journal Article
PL  - United States
TA  - P T
JT  - P & T : a peer-reviewed journal for formulary management
JID - 9015516
PMC - PMC6590928
OTO - NOTNLM
OT  - alpha-1 antitrypsin deficiency
OT  - chronic obstructive pulmonary disease
COIS- Disclosure: The authors report no commercial or financial interest in regard to 
      this article.
EDAT- 2019/07/02 06:00
MHDA- 2019/07/02 06:01
PMCR- 2019/08/01
CRDT- 2019/07/02 06:00
PHST- 2019/07/02 06:00 [entrez]
PHST- 2019/07/02 06:00 [pubmed]
PHST- 2019/07/02 06:01 [medline]
PHST- 2019/08/01 00:00 [pmc-release]
AID - ptj4407412 [pii]
PST - ppublish
SO  - P T. 2019 Jul;44(7):412-415.